Description: Cancer is often resistant to conventional chemotherapy protocols and therefore has poor clinical outcomes. Beyond chemotherapeutic agents, there are additional non-oncology drugs whose anticancer activity is sporadically reported in the medical literature. In most cases, neither patients nor healthcare professionals are aware of the clinically documented therapeutic potential of these remedies. Thus, their compassionate administration is not considered in the treatment of chemoresistant tumors. In layman language, I summarize notable therapeutic benefits observed in a clinical trial with non-Hodgkin lymphoma patients who were treated with 1 μg oral vitamin derivative daily. All of them (34 participants) had documented disease progression before starting the treatment. The drug used alone induced a complete and partial response in eight patients with an overall response rate of 24%. No drug toxicity was observed during the study. My medical and pharmaceutical background, combined with more than 22 years experience in the daily use of scientific databases, provide a solid basis for the preparation of such report which is supplied in electronic (PDF file) format. References https://scholar.google.com/citations?user=Gqu3u_oAAAAJ&hl=en https://www.scopus.com/authid/detail.uri?authorId=7004151908 https://www.researchgate.net/profile/Ferenc-Zsila
Price: 18 USD
Location: Budakeszi
End Time: 2024-10-20T20:56:30.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
